Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Collegium Pharmaceutical Inc    COLL

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/10/2017 10/11/2017 10/12/2017 10/13/2017 10/16/2017 Date
11.66(c) 11.83(c) 11.84(c) 11.36(c) 11.24(c) Last
539 368 491 803 428 510 511 776 314 271 Volume
-1.02% +1.46% +0.08% -4.05% -1.06% Change
More quotes
Financials ($)
Sales 2017 19,1 M
EBIT 2017 -88,1 M
Net income 2017 -88,6 M
Finance 2017 63,0 M
Yield 2017 -
Sales 2018 60,7 M
EBIT 2018 -57,7 M
Net income 2018 -58,3 M
Debt 2018 1,00 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 14,1x
EV / Sales2018 5,49x
Capitalization 332 M
More Financials
Company
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of next-generation abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases.Its products... 
Sector
Pharmaceuticals
Calendar
11/16Earnings Release
More about the company
Surperformance© ratings of Collegium Pharmaceutical I
Trading Rating : Investor Rating :
More Ratings
Latest news on COLLEGIUM PHARMACEUTICAL I
09/28 COLLEGIUM PHARMACEUTICAL : Patent Issued for Abuse-Deterrent Drug Formulations (..
09/06 Collegium to Present at Upcoming Investor Conferences
09/06 VANGUARD SHT TERM GOVT BOND ETF : Collegium Pharmaceutical, Inc. (COLL) Holdings..
09/05 Collegium Announces Scientific Presentations at PAINWeek 2017 Meeting
08/31 COLLEGIUM PHARMACEUTICAL : Patent Issued for Process of Making Stable Abuse-Dete..
08/24 BIODELIVERY SCIENCES INTERNATIONAL : President and Chief Executive Officer Dr. M..
08/09 COLLEGIUM PHARMACEUTICAL,INC. (NASDA : COLL) Files An 8-K Results of Operations ..
08/09 COLLEGIUM PHARMACEUTICAL, INC : Results of Operations and Financial Condition, C..
08/09 COLLEGIUM PHARMACEUTICAL : posts 2Q loss
08/09 COLLEGIUM PHARMACEUTICAL : Management's Discussion and Analysis of Financial Con..
More news
Sector news : Pharmaceuticals - NEC
10/16DJALLERGAN : Loses Patent Fight in Federal Court
10/16DJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
10/16 Miners provide foundation for FTSE while ConvaTec plummets
10/16 ASTRAZENECA : Pharma and medtech industries prepare for hard Brexit
10/16 CONVATEC : slashes revenue growth outlook, shares slump
More sector news : Pharmaceuticals - NEC
Latest Tweets
10/167 Stocks To Watch Amid #60Minutes DEA-Opioid Exposé
3
10/15Collegium Pharmaceutical, Inc. $COLL Shares Sold by ProShare Advisors LLC  
10/137 Stocks To Watch Ahead Of The 60 Minutes DEA-Opioid Exposé  
10/136 Stocks To Watch Ahead Of The #60Minutes DEA-Opioid Exposé
1
10/13SWING TRADE ALERT: $COLL technical alerts: Calm After Storm, Upper Bollinger .. 
More tweets
Qtime:32
News from SeekingAlpha
10/13 60 Minutes to run piece on opioid epidemic critical of suppliers this Sunday;..
10/05 PREMARKET GAINERS AS OF 9 : 05 am
10/04 Collegium inks deal with Cigna for Oxycodone equivalent; share rise 1%
09/28 WALL STREET BREAKFAST : Toshiba Signs Off On Chip Unit Sale
09/28 New measures to fight opioid addiction
Chart COLLEGIUM PHARMACEUTICAL I
Duration : Period :
Collegium Pharmaceutical I Technical Analysis Chart | COLL | US19459J1043 | 4-Traders
Technical analysis trends COLLEGIUM PHARMACEUTICAL I
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 19,2 $
Spread / Average Target 71%
EPS Revisions
Managers
NameTitle
Michael Thomas Heffernan Chairman, President & Chief Executive Officer
Joseph J. Ciaffoni Chief Operating Officer & Executive Vice President
Paul Brannelly CFO, Principal Accounting Officer & Executive VP
Alison Fleming Chief Technology Officer
Gino Santini Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
COLLEGIUM PHARMACEUTICAL INC-27.04%332
JOHNSON & JOHNSON18.42%366 178
NOVARTIS13.23%225 160
ROCHE HOLDING LTD.5.20%216 764
PFIZER11.88%216 409
MERCK AND COMPANY7.68%172 887